ERICA ROBLES: Open Payments
NPI 1790200368 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,717 in 71 payments from 13 companies in 2025. Trend: 2023 $590 · 2024 $1,225 · 2025 $1,717
Food & beverage: $1,717
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $368 |
| Lilly USA, LLC | 16 | $280 |
| Novo Nordisk Inc | 13 | $200 |
| Dexcom, Inc. | 4 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $145 |
| Exact Sciences Corporation | 10 | $140 |
| Optinose US, Inc. | 1 | $136 |
| PFIZER INC. | 4 | $100 |
| ABBVIE INC. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
Products named: FREESTYLE LIBRE 3, XIFAXAN, Cologuard Collection Kit, ZEPBOUND, Xhance, MOUNJARO, DEXCOM G7 GSS (161), Wegovy.
Industry payments across TX — which companies pay providers there.
